Combination of 4-1bb Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-14-0118
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Central Role of Tumor-Associated CD8+ T Effector/Memory Cells in Restoring Systemic Antitumor Immunity

Journal of Immunology
AllergyImmunology
2009English

Induction of Postsurgical Tumor Immunity and T-Cell Memory by a Poorly Immunogenic Tumor

Cancer Research
Cancer ResearchOncology
2007English

Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated With Increased PD-1 Expression on Effector CD8+ T Cells

Journal of Immunology
AllergyImmunology
2008English

Antibodies to Costimulatory Receptor 4-1bb Enhance Anti-Tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function

Immunity
Infectious DiseasesAllergyImmunology
2018English

4-1bb Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells With Similar Efficacy

Journal of Immunology
AllergyImmunology
2001English

TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1

Journal of Immunology
AllergyImmunology
2017English

IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells

Cancer Research
Cancer ResearchOncology
2015English

067 Highly Functional Skin NKG2D + CD8 + Effector Memory T Cells in Vitiligo

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

4-1bb Signaling Beyond T Cells

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy